Reflex Syncope Treatments: From Maneuvers to Pacing

Reflex syncope, the most common cause of fainting, is treated primarily through a layered approach that begins with education and lifestyle changes and escalates to medications, devices, or procedures only when simpler strategies fail. Because the underlying problem is not a structural heart defect but rather an exaggerated nervous-system reflex that temporarily drops blood pressure or heart rate, treatment aims to blunt that reflex or compensate for it. The good news is that most people improve substantially with non-drug strategies alone, though a meaningful minority need more aggressive options.

What Happens During an Episode

Reflex syncope occurs when the brainstem’s control center for blood pressure is triggered, either directly or indirectly, producing a surge of parasympathetic (vagal) activity and a simultaneous withdrawal of sympathetic tone. The result is a sudden drop in heart rate, blood pressure, or both, which starves the brain of blood flow and causes a brief loss of consciousness.¹ This reflex can be set off by prolonged standing, heat, emotional distress, pain, or specific triggers like coughing, urinating, or swallowing. Recognizing which trigger type you have matters for treatment, because some strategies work well for classic vasovagal fainting but are irrelevant for, say, cough syncope.

Physical Counterpressure Maneuvers

If you feel the warning signs of a faint coming on, specific muscle-tensing movements can abort the episode or at least buy you time to sit or lie down safely. The most studied maneuvers are leg crossing with tensing of the thigh and abdominal muscles, squatting, and hand gripping combined with arm tensing. These work by squeezing blood from the large veins in the legs and abdomen back toward the heart, temporarily raising blood pressure enough to keep the brain perfused.

A meta-analysis of studies testing these maneuvers found that roughly 60% of patients improved in laboratory settings and about 70% improved in real-world use.² A randomized trial, the PC-Trial, found that patients trained to perform counterpressure maneuvers had a significantly lower yearly rate of fainting compared with controls, and the study’s authors recommended the technique as first-line treatment for anyone who gets recognizable warning symptoms before fainting.³ The maneuvers are cost-free and carry no risk, which is why virtually every guideline lists them as step one. Their main limitation is practical: you need to recognize the prodrome in time, and you need to be in a position where tensing your legs or squatting is physically possible.

Salt, Water, and Compression Garments

Boosting blood volume is one of the simplest ways to make yourself more resistant to the blood-pressure drop that causes fainting. For most people this means drinking more water and increasing dietary salt, which helps the body retain that extra fluid. A meta-analysis of pediatric studies found that increased salt and water intake reduced the recurrence of fainting or near-fainting episodes from about 60% in control groups to roughly 44% in the intervention groups, a significant difference.⁴ These findings are commonly extrapolated to adults, though the strongest controlled data come from younger patients.

Compression garments, particularly stockings that squeeze the legs, take a similar approach by preventing blood from pooling in the lower body when you stand. A randomized crossover study found that lower-limb compression rendered the tilt test negative in 90% of patients who previously fainted during it, compared with only 35% without compression.⁵ The catch is compliance: medical-grade compression stockings are uncomfortable, hot, and difficult to put on, so many patients stop wearing them after a few weeks. Waist-high compression tends to work better than knee-high, because a lot of blood pools in the abdomen, not just the calves.

Tilt Training

Tilt training involves standing against a wall with your heels a few inches from the baseboard for 20 to 30 minutes once or twice daily, deliberately exposing yourself to the upright posture that provokes your reflex. The idea is that repeated controlled exposure desensitizes the reflex over time. Early unblinded studies were extremely enthusiastic: one reported complete disappearance of fainting in all 13 patients who completed the program, and a controlled trial in adolescents found that after a month of training, none of the trained patients fainted during follow-up compared with more than half of controls.⁶⁷

However, a randomized single-blind study that addressed some of the methodological weaknesses of earlier work found no significant difference between the training group and controls in either tilt-test outcomes or time to syncope.⁸ The likely explanation is that adherence drops sharply once the novelty wears off. Standing motionless against a wall for half an hour every day is boring and time-consuming, and the benefits seem to evaporate quickly once you stop. If you are motivated enough to keep it up, tilt training might help, but most clinicians no longer push it as a primary strategy because real-world sticking rates are poor.

Medications

When lifestyle measures and maneuvers are not enough, several drugs have at least some evidence behind them, though none is a slam dunk.

Midodrine

Midodrine is an oral drug that tightens blood vessels, raising baseline blood pressure and making the reflex drop less likely to reach the threshold for fainting. A systematic review and meta-analysis found that midodrine roughly halved the likelihood of a positive tilt test, and in the two most rigorous double-blind placebo-controlled trials, it reduced the risk of clinical fainting by about 30%.⁹ One of those trials, involving 133 patients, found that 42% of those on midodrine fainted during follow-up versus 61% on placebo, with a number needed to treat of about five, meaning you need to treat five people for one to benefit.¹⁰ Midodrine’s downsides include scalp tingling, goosebumps, and the need to take it several times daily. It also raises blood pressure while lying down, so it is generally taken only during waking hours.

Fludrocortisone

Fludrocortisone is a synthetic steroid that makes the kidneys retain sodium and water, expanding blood volume.¹¹ A large randomized placebo-controlled trial found that after an initial dose-stabilization period, fludrocortisone cut the risk of fainting by about half compared with placebo, though the headline result was only borderline significant until the analysis accounted for the slow ramp-up phase.¹² One pediatric observational study did not find a blood-pressure increase with fludrocortisone, possibly because the doses used were too low.¹³ In practice, fludrocortisone is often tried in younger patients who tolerate the slight fluid retention well, though long-term steroid effects like low potassium need monitoring.

Beta-Blockers

Beta-blockers were once widely prescribed for vasovagal syncope based on the theory that blocking adrenaline’s effects on the heart would prevent the reflex from firing. Across unselected populations, however, they have consistently failed to show clear benefit. What has emerged from pooled data is an age-dependent effect: in patients over roughly 42 years old, beta-blockers appear to cut the risk of syncope by about half, whereas in younger patients the risk actually trends upward.¹⁴ If you are middle-aged or older and already taking a beta-blocker for another reason, it might be pulling double duty. But prescribing one to a young person specifically for fainting is not well supported.

SSRIs

Selective serotonin reuptake inhibitors, a class of antidepressants, have a theoretical basis here because serotonin plays a role in the brainstem circuits that mediate the vasovagal reflex. A systematic review found that SSRIs reduced the risk of having at least one recurrence of fainting by about two-thirds, with minimal differences between studies.¹⁵ One of the stronger individual trials, using paroxetine, found that only about 18% of treated patients fainted during follow-up versus 53% on placebo.¹⁶ Despite these promising numbers, SSRIs are not yet widely adopted for syncope because the trials have been small, the side-effect profile is not trivial, and many clinicians are uncomfortable prescribing an antidepressant off-label for a condition that is not psychiatric. Still, for people with refractory fainting who have failed other options, they represent a reasonable conversation to have with a specialist.

Cardiac Pacing

In a subset of patients whose reflex causes a dramatic slowing or outright stopping of the heart (the “cardioinhibitory” type), a pacemaker can prevent the dangerous pause. The technology that has attracted the most attention is called closed-loop stimulation, or CLS. Unlike a standard pacemaker that kicks in only when the heart rate falls below a preset floor, CLS monitors changes in the heart’s own electrical impedance, which shifts before the heart rate actually drops. This lets it start pacing a few seconds earlier, heading off the faint before the patient hits the floor.

A systematic review of CLS pacing found that it reduced recurrent fainting by up to 80% compared with conventional pacing modes.¹⁷ The SPAIN study, a double-blind crossover trial, reported that only about 9% of patients experienced syncope during the CLS-active phase compared with 46% during the sham phase.¹⁸ The INVASY trial found no syncope at all during a mean follow-up of nearly 19 months in the CLS arm.¹⁹ Pacing is not appropriate for most people with reflex syncope; it is reserved for those who faint frequently, who have documented prolonged heart pauses, and who have not responded to other treatments.

Cardioneuroablation

A newer and still experimental approach uses catheter ablation inside the heart to destroy clusters of nerve cells (ganglionic plexi) that relay the vagal signal responsible for the heart-rate drop. A prospective randomized trial found that only 8% of patients who underwent cardioneuroablation had a recurrence, compared with 54% in the control group.²⁰ A longer-term observational study with a mean follow-up of nearly four years found that the cardioinhibitory reflex disappeared almost completely in the ablated patients, and the few who did have mild recurrences showed attenuated responses that became manageable with simple medication or salt intake.²¹ The procedure is still considered investigational in most centers and is typically offered only to patients with severe, refractory cardioinhibitory syncope who are not satisfied with or are poor candidates for a pacemaker.²²

Using an Implantable Loop Recorder to Guide Treatment

One of the trickiest aspects of reflex syncope is that episodes are unpredictable and may happen only a few times a year, making it hard to capture what the heart is doing during a faint. An implantable loop recorder, a tiny device inserted under the skin of the chest, continuously monitors the heart rhythm and stores a recording whenever it detects an abnormality or the patient activates it after a spell. A large prospective study found that when treatment was guided by what the recorder actually documented during a faint, the one-year recurrence rate dropped to 10%, compared with 41% in patients who received no specific therapy, an 80% relative risk reduction.²³ Among patients in whom the recorder documented a long heart pause, most received a pacemaker; a few had a fast rhythm that warranted different treatment entirely.²⁴ A final diagnosis was reached in over half of patients within about 18 months of implantation.²⁵ The recorder does not treat anything by itself, but it transforms guesswork into evidence-based decision-making.

Situational and Carotid Sinus Subtypes

Not all reflex syncope is the classic vasovagal faint triggered by standing or emotional stress. Situational syncope occurs when a specific physical act fires the reflex: coughing, swallowing, urinating, straining on the toilet, or even laughing. Treatment for these subtypes starts with addressing the trigger itself. For micturition syncope, sitting to urinate (especially at night) and performing counterpressure maneuvers can prevent episodes. For cough syncope, treating the underlying cough with appropriate medication matters more than any anti-fainting strategy.²⁶ Pacing is rarely needed, because the heart-slowing component is usually less prominent in situational variants.²⁷

Carotid sinus syndrome is another subtype in which pressure on the carotid artery in the neck, sometimes just from turning the head or wearing a tight collar, triggers the reflex. When the dominant response is a long heart pause, dual-chamber pacing is the standard treatment and tends to work best in patients who do not also have a significant blood-pressure drop component.²⁸ When the blood-pressure drop is the main problem, treatment is often frustrating: reducing or discontinuing blood-pressure-lowering medications already being taken for other reasons may be the most effective move.

Cognitive Behavioral Therapy

Anxiety about fainting can itself feed the reflex by heightening sympathetic arousal and hyperventilation, creating a vicious cycle. Cognitive behavioral therapy has been tested in small pilot studies of patients whose syncope resisted conventional treatment. In one series of nine patients, CBT led to significant reductions in fainting episodes and medical consultations, and all participants were able to return to work or school.²⁹ A subsequent small study reported improved emotional well-being and reduced fainting frequency in three of four participants.³⁰ The evidence here is preliminary, but the logic is sound: if fear and avoidance behaviors are making your fainting worse, addressing them psychologically can break the cycle. CBT is best viewed as a complement to physical and pharmacological strategies, not a replacement.

Special Considerations for Children and Adolescents

Fainting is extremely common in young people and almost always reflects reflex syncope rather than a dangerous heart condition. The natural history in children is generally favorable, with most outgrowing the tendency or seeing it improve substantially on its own.³¹ Treatment in this age group leans heavily on education, reassurance, hydration, salt supplementation, and physical counterpressure maneuvers. Medications are used sparingly, both because the evidence base is thinner in pediatric populations and because the prognosis is good enough that aggressive pharmacotherapy rarely seems justified. Updated pediatric guidelines emphasize individualized treatment based on the specific trigger and pattern of fainting.³² The main clinical challenge is distinguishing benign reflex syncope from the rare cardiac cause, which is why any young patient with exertional fainting, a family history of sudden death, or abnormal exam findings deserves a thorough cardiac workup.

Wearable Technology and Early Warning Systems

One of the most promising developments is the possibility that a smartwatch or wearable sensor could warn you before you faint. A recent study demonstrated that an artificial intelligence model analyzing heart-rate variability data from a smartwatch’s optical sensor could predict an impending vasovagal episode during a tilt test with clinically meaningful accuracy, even with a five-minute lead time before the faint.³³ Wearable multi-sensor systems that combine heart rhythm and pulse-wave data have also been shown to be feasible for predicting reflex syncope outside of the lab.³⁴ This technology is still in early stages and not yet available as a consumer product for syncope prediction, but it could eventually close the gap for patients who faint without any warning symptoms and therefore cannot use counterpressure maneuvers in time.

Why the Reflex Exists at All

It may seem odd that evolution would preserve a reflex that causes people to collapse. Researchers have proposed that the vasovagal reflex is not a malfunction but rather a defense mechanism inherited from ancient vertebrates. One hypothesis holds that the sudden drop in blood pressure and heart rate evolved to limit blood loss during hemorrhage: by lowering the pressure driving blood out of a wound, the reflex gives clots a chance to form.³⁵ Another line of evidence connects vasovagal syncope to the “freeze” or tonic immobility response seen across many animal species when confronted by a predator, which involves a similar combination of bradycardia and behavioral stillness.³⁶ The fact that this reflex has persisted across vertebrate lineages for millions of years suggests it is doing something useful in certain survival scenarios, even if in modern life it mostly just causes embarrassing falls in grocery stores and subway stations.³⁷ Understanding this evolutionary context does not change treatment, but it does reframe the condition: reflex syncope is not a sign that something is broken. It is an overly enthusiastic survival program running in a context it was never designed for.

1
PubMed Central. The Role of the Autonomic Nervous System in Vasovagal Syncope ↩︎
2
PubMed Central. Counter pressure maneuvers for syncope prevention: A semi-systematic review and meta-analysis ↩︎
3
PubMed. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial) ↩︎
4
PubMed Central. Efficacy of Increased Salt and Water Intake on Pediatric Vasovagal Syncope: A Meta-Analysis Based on Global Published Data ↩︎
5
PubMed. Efficacy of lower limb compression in the management of vasovagal syncope–randomized, crossover study ↩︎
6
PubMed. Tilt training: a new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance ↩︎
7
PubMed. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: A controlled study ↩︎
8
EP Europace. Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study ↩︎
9
PubMed Central. Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis ↩︎
10
PubMed. Midodrine for the Prevention of Vasovagal Syncope : A Randomized Clinical Trial ↩︎
11
PubMed. Pharmacological treatment of reflex syncope ↩︎
12
PubMed. Fludrocortisone for the Prevention of Vasovagal Syncope: A Randomized, Placebo-Controlled Trial ↩︎
13
PubMed Central. Fludrocortisone in Pediatric Vasovagal Syncope: A Retrospective, Single-Center Observational Study ↩︎
14
PubMed. Age-dependent effect of β-blockers in preventing vasovagal syncope ↩︎
15
PubMed. Serotonin reuptake inhibition for the prevention of vasovagal syncope: a systematic review and meta-analysis ↩︎
16
PubMed. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study ↩︎
17
PubMed Central. Closed-looped stimulation cardiac pacing for recurrent vasovagal syncope: A systematic review and meta-analysis ↩︎
18
PubMed. Dual-Chamber Pacing With Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope: The SPAIN Study ↩︎
19
EP Europace. Closed loop stimulation in prevention of vasovagal syncope. Inotropy controlled pacing in vasovagal syncope (INVASY): a multicentre randomized, single blind, controlled study ↩︎
20
PubMed. Cardioneuroablation for Reflex Syncope: Efficacy and Effects on Autonomic Cardiac Regulation-A Prospective Randomized Trial ↩︎
21
EP Europace. Catheter ablation of severe neurally meditated reflex syncope: cardioneuroablation long-term results ↩︎
22
PubMed. Cardioneuroablation: a new treatment for vasovagal syncope ↩︎
23
European Heart Journal. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope ↩︎
24
PubMed Central. Use of implantable and external loop recorders in syncope with unknown causes ↩︎
25
PubMed. Effectiveness and safety of implantable loop recorder and clinical utility of remote monitoring in patients with unexplained, recurrent, traumatic syncope ↩︎
26
PubMed Central. Reflex syncope: Diagnosis and treatment ↩︎
27
PubMed. New approaches to the treatment and prevention of neurally mediated reflex (neurocardiogenic) syncope ↩︎
28
PubMed Central. Carotid sinus syndrome: Progress in understanding and management ↩︎
29
PubMed. Cognitive behavioural therapy as a potential treatment for vasovagal/neurocardiogenic syncope–a pilot study ↩︎
30
International Journal of Clinical Medicine. A Cognitive Behavioural Intervention for the Treatment of Vasovagal and Unexplained Syncope ↩︎
31
PubMed Central. Syncope in children and adolescents: Evaluation and treatment ↩︎
32
PubMed Central. Guidelines for the diagnosis and treatment of neurally mediated syncope in children and adolescents (revised 2024) ↩︎
33
European Heart Journal – Digital Health. Prediction of vasovagal syncope using artificial intelligence-enabled smartwatch photoplethysmography-derived heart rate variability ↩︎
34
PubMed Central. Wearable Sensors in Syncope Management ↩︎
35
PubMed. Vasovagal syncope and Darwinian fitness ↩︎
36
PubMed Central. Vasovagal Syncope As A Manifestation Of An Evolutionary Selected Trait ↩︎
37
EP Europace. Vasovagal syncope in humans and protective reactions in animals ↩︎